InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.42
(
-0.20%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,089.49
(
0.15%
)
Brent Oil
74.26
(
-0.09%
)
Bitcoin
62,649.15
(
-0.48%
)
Post# of 253167
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 47
Posts 4694
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 232324

Thursday, 05/14/2020 8:54:08 AM

Thursday, May 14, 2020 8:54:08 AM

Post# of 253167
This is interesting from a scientific standpoint, but as you know doesn't move the needle for MRK
BMY and SGEN now have several studies looking at PD-1 plus BV in first line HL
SGEN is looking at Padcev plus Keytruda in bladder cancer though which would be a larger market
ADCs seem to combine well w PD-1s so far
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up